In a world first, the US Food and Drug Administration has given the go-ahead for a 3D-printed pill to be produced. The FDA has previously approved medical devices – including prosthetics – that have been 3D printed. The new drug, dubbed Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy.
The company said that it planned to develop other medications using its 3D platform. Printing the drugs allows layers of medication to be packaged more tightly in precise dosages. Printing the drug meant it could package up to 1,000 milligrams into individual tablets. The 3D-printed pill dissolves in the same manner as other oral medicines.
Being able to 3D print a tablet offers the potential to create bespoke drugs based on the specific needs of patients, rather than having a one product fits all approach, according to experts. Edited from: First 3D-printed pill approved by US authorities